Sun Pharmacy presently trades on the higher side on the Sensex after the company got a hesitant consent from the USFDA for its ANDA for the generic edition of Optivar.
The stock presently trades at Rs.1160.05 on each share, which is high with 14.20 points on the Sensex.
The stock hit at Rs.1148 as opposed to its earlier close of Rs.1145.85. The stock has reached an intraday up and a down of Rs.1166.90 and Rs.1146.05, correspondingly.
Till now, 7,865 company’s shares have been traded on the Sensex.
The stock reached its 52-week up of Rs.1600 on 19th May and a 52-week down of Rs.953 on 4th March.
The stock has earned 1.72% since last week, but fell 7.54% since last month.